{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:43Z","timestamp":1761536263110,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1111\/jth.15645","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T23:31:37Z","timestamp":1647819097000},"page":"1019-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cVon Willebrand disease type 2M: Correlation between genotype and phenotype\u201d: Comment from Favaloro"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/jth.15645_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jth.15586","article-title":"Von Willebrand disease type 2M: correlation between genotype and phenotype","volume":"20","author":"Maas","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1111\/jth.15645_bb0015","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1055\/s-0041-1726097","article-title":"Type 2A and 2M von Willebrand disease: differences in phenotypic parameters according to the affected domain by disease\u2010causing variants and assessment of pathophysiological mechanisms","volume":"47","author":"Woods","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1111\/jth.15645_bb0020","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease \u2013 more often misidentified than correctly identified","volume":"22","author":"Favaloro","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15645_bb0025","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays","author":"Favaloro","year":"2021","journal-title":"Pathology"},{"issue":"2","key":"10.1111\/jth.15645_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease in the real world","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15645_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2018.04.015","article-title":"Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: a large international cross\u2010laboratory study","volume":"166","author":"Favaloro","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"10.1111\/jth.15645_bb0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/bloodadvances.2021005946","article-title":"Commentary on \"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD\": reflections based on recent contemporary test data","volume":"6","author":"Favaloro","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1111\/jth.15645_bb0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1111\/jth.15645_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hae.14204","article-title":"How we diagnose 2M von Willebrand disease (VWD): use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types","volume":"27","author":"Favaloro","year":"2021","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15645","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15645","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:33:55Z","timestamp":1761536035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1538783622001362"],"URL":"https:\/\/doi.org\/10.1111\/jth.15645","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cVon Willebrand disease type 2M: Correlation between genotype and phenotype\u201d: Comment from Favaloro","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}